510(k) K981567

HYBRID CAPTURE II CT/GC TEST by Digene Corp. — Product Code LSL

K981567 is an FDA 510(k) premarket notification submitted by Digene Corp. for the device "HYBRID CAPTURE II CT/GC TEST". The FDA issued a decision of Substantially Equivalent on February 29, 2000. The device falls under product code LSL (Dna-Reagents, Neisseria), a Class II device regulated under 21 CFR 866.3390. Digene Corp. has at least 8 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
February 29, 2000
Date Received
May 1, 1998
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Dna-Reagents, Neisseria
Device Class
Class II
Regulation Number
866.3390
Review Panel
MI
Submission Type